ALS Breakthrough: Experimental Drug Enables Woman to Walk Again

Columbia University researchers report a major breakthrough in ALS treatment. A new experimental drug, ulefnersen, has enabled a young woman with a severe, genetic form of ALS to walk and breathe unaided. The drug has reversed damage previously thought irreversible. In another case, the drug prevented the onset of ALS symptoms. "This is a recovery without precedent," stated a Columbia University spokesperson. The study, published in The Lancet, offers hope for earlier and more precise treatment of ALS. The results demonstrate the potential to halt and even reverse the disease's progression when caught early. This advancement marks a turning point in the fight against ALS.